Biodiversity Offers Insight into the Ecosystem of Liver Cancer

Priyanshi Patel ’22 Liver cancer is the second most lethal malignancy in the world and includes mainly hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (iCCA). HCC is the most common type of primary liver cancer and often occurs in people with chronic liver diseases. iCCA is also a cancer that develops within the bile duct, whereas HCC occurs among alcoholics or those with fat accumulation in … Continue reading Biodiversity Offers Insight into the Ecosystem of Liver Cancer

In Situ Administration of Cytokine Combinations Could Be the Future of Immunotherapy

By Riya Gandhi ‘22 Rather than look outwards for new cancer treatments, scientists are beginning to look inwards – that is, inside the human body – for advanced therapeutic treatments. Although the use of cytokines, biomolecules that direct an immune response,in cancer therapy has been attempted for decades, there is still room for much improvement. In a recent study on cytokines, researchers under the guidance … Continue reading In Situ Administration of Cytokine Combinations Could Be the Future of Immunotherapy

Targeting Non-Dividing Cells in Cancer

By Cerise Carey Invasive cells, ones that travel from tumor tissue to form new tumors elsewhere within the host, have been the focus of most cancer research. In a recent study, Dr. David Q. Matus, an Assistant Professor in the Stony Brook University Department of Biochemistry & Cell Biology, and his colleagues found that cells in the roundworm nematode C. elegans cannot divide and invade … Continue reading Targeting Non-Dividing Cells in Cancer